My Quote Request
No products added yet
6505-01-230-6227
20 Products
Y101
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012306227
NSN
6505-01-230-6227
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 180.000 MILLIGRAMS IODINE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOHEXOL INJECTION STERILE 180MG/ML 10ML CONTAINER 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
TOLINASE TABLETS
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505012303133
NSN
6505-01-230-3133
TOLINASE TABLETS
TOLAZAMIDE TABLETS,USP
NSN, MFG P/N
6505012303133
NSN
6505-01-230-3133
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS TOLAZAMIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: LEDERLE MEDSEP ITEM FOR DOD
Related Searches:
NDC00005-3172-34
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012303137
NSN
6505-01-230-3137
NDC00005-3172-34
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012303137
NSN
6505-01-230-3137
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PROTECTIVE STORAGE FEATURE:SECURITY STORAGE;CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV;
Related Searches:
NDC00555-0371-05
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012303137
NSN
6505-01-230-3137
NDC00555-0371-05
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012303137
NSN
6505-01-230-3137
MFG
BARR PHARMACEUTICALS LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PROTECTIVE STORAGE FEATURE:SECURITY STORAGE;CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV;
Related Searches:
NDC00005-3173-31
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012303138
NSN
6505-01-230-3138
NDC00005-3173-31
LORAZEPAM TABLETS,USP
NSN, MFG P/N
6505012303138
NSN
6505-01-230-3138
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
NDC00054-4496-13
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012303140
NSN
6505-01-230-3140
NDC00054-4496-13
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012303140
NSN
6505-01-230-3140
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS LEUCOVORIN EQUIVALENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEUCOVORIN CALCIUM TABLETS EQUIVALENT TO 5MG OF LEUCOVORIN 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: LEDERLE LABORATORIES
Related Searches:
NDC00074-7418-03
DEXTRAN 40 AND DEXTROSE INJECTION
NSN, MFG P/N
6505012303143
NSN
6505-01-230-3143
NDC00074-7418-03
DEXTRAN 40 AND DEXTROSE INJECTION
NSN, MFG P/N
6505012303143
NSN
6505-01-230-3143
MFG
ABBOTT LABORATORIES DIAGNOSTICS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DEXTRAN 40 ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTRAM 40 AND DEXTROSE INJECTION 500ML BAG 12S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: IN OVERPOUCH; W/HANGER STRAP
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC47679-0526-35
CALCIUM CARBONATE AND VITAMIN D TABLETS
NSN, MFG P/N
6505012303929
NSN
6505-01-230-3929
NDC47679-0526-35
CALCIUM CARBONATE AND VITAMIN D TABLETS
NSN, MFG P/N
6505012303929
NSN
6505-01-230-3929
MFG
BAXTER HEALTHCARE CORP PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CALCIUM CARBONATE ACTIVE INGREDIENT AND 125.000 INTERNATIONAL UNITS ERGOCALCIFEROL ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: ASCOT PHARM.
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00338-0035-65
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012303930
NSN
6505-01-230-3930
NDC00338-0035-65
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012303930
NSN
6505-01-230-3930
MFG
BAXTER HEALTHCARE CORP FENWAL DIV GOVERNMENT SALES LCII-03
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
COMPAZINE
PROCHLORPERAZINE EDISYLATE INJECTION,USP
NSN, MFG P/N
6505012303931
NSN
6505-01-230-3931
COMPAZINE
PROCHLORPERAZINE EDISYLATE INJECTION,USP
NSN, MFG P/N
6505012303931
NSN
6505-01-230-3931
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PROCHLORPERAZINE EDISYLATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROCHLORPERAZINE EDISYLATE INJECTION USP 5MG/ML 2ML AMPUL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: ELKINS-SINN,INC.
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00641-0491-25
PROCHLORPERAZINE EDISYLATE INJECTION,USP
NSN, MFG P/N
6505012303931
NSN
6505-01-230-3931
NDC00641-0491-25
PROCHLORPERAZINE EDISYLATE INJECTION,USP
NSN, MFG P/N
6505012303931
NSN
6505-01-230-3931
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PROCHLORPERAZINE EDISYLATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROCHLORPERAZINE EDISYLATE INJECTION USP 5MG/ML 2ML AMPUL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: ELKINS-SINN,INC.
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
410-9002
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505012305268
NSN
6505-01-230-5268
410-9002
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505012305268
NSN
6505-01-230-5268
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 2.000 MILLIGRAMS COPPER SULFATE ACTIVE INGREDIENT AND 6.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 15.000 INTERNATIONAL UNITS DL-ALPHA-TOCOPHERYL ACETATE ACTIVE INGREDIENT AND 400.000
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
~1: INTERNATIONAL UNITS ERGOCALCIFEROL ACTIVE INGREDIENT AND 0.400 MILLIGRAMS FOLIC ACID ACTIVE INGREDIENT AND 18.000 MILLIGRAMS IRON ACTIVE INGREDIENT AND 1.000 MILLIGRAMS MANGANESE SULFATE ACTIVE INGREDIENT AND 20.000 MILLIGRAMS NIACINAMIDE ACTIVE
~2: INGREDIENT AND 10.000 MILLIGRAMS PANTOTHENIC ACID ACTIVE INGREDIENT AND 5.000 MILLIGRAMS POTASSIUM ACTIVE INGREDIENT AND 150.000 MICROGRAMS POTASSIUM IODIDE ACTIVE INGREDIENT AND 2.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT AND 5000.000
~3: INTERNATIONAL UNITS RETINOL ACTIVE INGREDIENT AND 1.700 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 1.500 MILLIGRAMS THIAMINE MONONITRATE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS ZINC OXIDE ACTIVE INGREDIENT
Related Searches:
NDC00364-1090-02
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505012305268
NSN
6505-01-230-5268
NDC00364-1090-02
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505012305268
NSN
6505-01-230-5268
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 2.000 MILLIGRAMS COPPER SULFATE ACTIVE INGREDIENT AND 6.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 15.000 INTERNATIONAL UNITS DL-ALPHA-TOCOPHERYL ACETATE ACTIVE INGREDIENT AND 400.000
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
~1: INTERNATIONAL UNITS ERGOCALCIFEROL ACTIVE INGREDIENT AND 0.400 MILLIGRAMS FOLIC ACID ACTIVE INGREDIENT AND 18.000 MILLIGRAMS IRON ACTIVE INGREDIENT AND 1.000 MILLIGRAMS MANGANESE SULFATE ACTIVE INGREDIENT AND 20.000 MILLIGRAMS NIACINAMIDE ACTIVE
~2: INGREDIENT AND 10.000 MILLIGRAMS PANTOTHENIC ACID ACTIVE INGREDIENT AND 5.000 MILLIGRAMS POTASSIUM ACTIVE INGREDIENT AND 150.000 MICROGRAMS POTASSIUM IODIDE ACTIVE INGREDIENT AND 2.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT AND 5000.000
~3: INTERNATIONAL UNITS RETINOL ACTIVE INGREDIENT AND 1.700 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 1.500 MILLIGRAMS THIAMINE MONONITRATE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS ZINC OXIDE ACTIVE INGREDIENT
Related Searches:
UNAVIT M
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505012305268
NSN
6505-01-230-5268
UNAVIT M
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505012305268
NSN
6505-01-230-5268
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 2.000 MILLIGRAMS COPPER SULFATE ACTIVE INGREDIENT AND 6.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 15.000 INTERNATIONAL UNITS DL-ALPHA-TOCOPHERYL ACETATE ACTIVE INGREDIENT AND 400.000
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
~1: INTERNATIONAL UNITS ERGOCALCIFEROL ACTIVE INGREDIENT AND 0.400 MILLIGRAMS FOLIC ACID ACTIVE INGREDIENT AND 18.000 MILLIGRAMS IRON ACTIVE INGREDIENT AND 1.000 MILLIGRAMS MANGANESE SULFATE ACTIVE INGREDIENT AND 20.000 MILLIGRAMS NIACINAMIDE ACTIVE
~2: INGREDIENT AND 10.000 MILLIGRAMS PANTOTHENIC ACID ACTIVE INGREDIENT AND 5.000 MILLIGRAMS POTASSIUM ACTIVE INGREDIENT AND 150.000 MICROGRAMS POTASSIUM IODIDE ACTIVE INGREDIENT AND 2.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT AND 5000.000
~3: INTERNATIONAL UNITS RETINOL ACTIVE INGREDIENT AND 1.700 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 1.500 MILLIGRAMS THIAMINE MONONITRATE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS ZINC OXIDE ACTIVE INGREDIENT
Related Searches:
NDC00173-0393-40
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505012306004
NSN
6505-01-230-6004
NDC00173-0393-40
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505012306004
NSN
6505-01-230-6004
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS RANITIDINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 300MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ZANTAC
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505012306004
NSN
6505-01-230-6004
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS RANITIDINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 300MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ZANTAC TABLETS
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505012306004
NSN
6505-01-230-6004
ZANTAC TABLETS
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505012306004
NSN
6505-01-230-6004
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS RANITIDINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE TABLETS USP 300MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00024-1411-10
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012306227
NSN
6505-01-230-6227
NDC00024-1411-10
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012306227
NSN
6505-01-230-6227
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 180.000 MILLIGRAMS IODINE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOHEXOL INJECTION STERILE 180MG/ML 10ML CONTAINER 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00407-1411-10
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012306227
NSN
6505-01-230-6227
NDC00407-1411-10
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012306227
NSN
6505-01-230-6227
MFG
GE HEALTH DBA GE HEALTHCARE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 180.000 MILLIGRAMS IODINE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOHEXOL INJECTION STERILE 180MG/ML 10ML CONTAINER 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
OMNIPAQUE 180
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012306227
NSN
6505-01-230-6227
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 180.000 MILLIGRAMS IODINE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOHEXOL INJECTION STERILE 180MG/ML 10ML CONTAINER 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
